Bing Wu

1.4k total citations
59 papers, 861 citations indexed

About

Bing Wu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Bing Wu has authored 59 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 15 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Bing Wu's work include Immune Cell Function and Interaction (15 papers), Immunotherapy and Immune Responses (11 papers) and T-cell and B-cell Immunology (11 papers). Bing Wu is often cited by papers focused on Immune Cell Function and Interaction (15 papers), Immunotherapy and Immune Responses (11 papers) and T-cell and B-cell Immunology (11 papers). Bing Wu collaborates with scholars based in China, United States and Brazil. Bing Wu's co-authors include Yisong Y. Wan, Zengli Guo, Bin Wang, Jenny P.‐Y. Ting, Song Zhang, Xiaojiang Xu, Shuang Geng, Gang Wang, Qiang Zou and Di Wu and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Bing Wu

50 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Wu China 14 400 285 155 112 106 59 861
Yu Si China 21 334 0.8× 385 1.4× 183 1.2× 92 0.8× 121 1.1× 81 1.1k
Kiva Brennan Ireland 14 618 1.5× 351 1.2× 135 0.9× 166 1.5× 101 1.0× 26 1.1k
Tara A. Sheldrake United Kingdom 13 468 1.2× 376 1.3× 143 0.9× 125 1.1× 59 0.6× 18 1.0k
Cynthia Louis Australia 15 705 1.8× 423 1.5× 182 1.2× 100 0.9× 102 1.0× 23 1.1k
Lucía Cabal‐Hierro United States 10 270 0.7× 316 1.1× 172 1.1× 107 1.0× 130 1.2× 16 796
Yeny Martinez de la Torre Italy 10 726 1.8× 299 1.0× 225 1.5× 84 0.8× 98 0.9× 11 1.0k
David Saliba United Kingdom 14 562 1.4× 375 1.3× 171 1.1× 107 1.0× 179 1.7× 19 970
Tiina Kelkka Finland 18 703 1.8× 295 1.0× 129 0.8× 85 0.8× 69 0.7× 30 1.1k
Morteza Motallebnezhad Iran 19 382 1.0× 390 1.4× 230 1.5× 111 1.0× 98 0.9× 37 1.1k
Simone Vogel Germany 13 377 0.9× 233 0.8× 150 1.0× 74 0.7× 118 1.1× 24 848

Countries citing papers authored by Bing Wu

Since Specialization
Citations

This map shows the geographic impact of Bing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Wu more than expected).

Fields of papers citing papers by Bing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Wu. The network helps show where Bing Wu may publish in the future.

Co-authorship network of co-authors of Bing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Wu. A scholar is included among the top collaborators of Bing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Wu. Bing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yuan‐Han, Zhao Hu, Chuanming Wang, et al.. (2025). Bi2O2Se nanosheets coated with rosmarinic acid for colon-targeted treatment of inflammatory bowel disease. Chemical Engineering Journal. 506. 160230–160230.
2.
Wu, Bing, et al.. (2025). Anti-Cancer Properties and Mechanistic Insights of Dihydroquercetin. Current Pharmaceutical Biotechnology. 26. 1 indexed citations
3.
Huang, Mingquan, Shaozhi Fu, Yu Wang, et al.. (2025). ADCY4 inhibits cAMP-induced growth of breast cancer by inactivating FAK/AKT and ERK signaling but is frequently silenced by DNA methylation. Scientific Reports. 15(1). 20426–20426. 1 indexed citations
4.
5.
Sun, Shiyu, Junyi Ma, Xuelong Wang, et al.. (2024). Histamine H4 receptor and TRPV1 mediate itch induced by cadaverine, a metabolite of the microbiome. Molecular Pain. 20. 824473429–824473429.
6.
Wang, Chenwei, Jiewen Chen, Jingyao Li, et al.. (2024). An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model. Journal of Clinical Investigation. 134(8). 3 indexed citations
7.
Hu, Jin, et al.. (2024). METTL3 governs thymocyte development and thymic involution by regulating ferroptosis. Nature Aging. 4(12). 1813–1827. 8 indexed citations
8.
Wu, Bing, et al.. (2023). Multimodal imaging of morning glory syndrome with persistent hyperplastic primary vitreous. Journal of Clinical Ultrasound. 51(8). 1364–1365. 1 indexed citations
9.
Jiang, Hao, et al.. (2023). Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients. World Journal of Gastroenterology. 29(35). 5166–5177. 7 indexed citations
10.
Wu, Bing, Kirat K. Chand, Stephanie Miller, et al.. (2023). Effects of fetal growth restriction on the perinatal neurovascular unit and possible treatment targets. Pediatric Research. 95(1). 59–69. 5 indexed citations
11.
Wu, Bing, Yan Wang, Sahil Kapoor, et al.. (2022). Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells. The Journal of Immunology. 209(1). 49–56. 3 indexed citations
12.
Peng, Long, Yidan Sun, Bing Wu, et al.. (2022). COMMD4 is a novel prognostic biomarker and relates to potential drug resistance mechanism in glioma. Frontiers in Pharmacology. 13. 974107–974107. 2 indexed citations
13.
Wu, Bing, Song Zhang, Zengli Guo, et al.. (2021). The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation. Immunity. 54(2). 308–323.e6. 71 indexed citations
14.
Wang, Ziheng, Shiqi Ren, Wei Wang, et al.. (2021). SCAMP4 is a novel prognostic marker and correlated with the tumor progression and immune infiltration in glioma. The International Journal of Biochemistry & Cell Biology. 139. 106054–106054. 14 indexed citations
15.
Wu, Bing, Ge Zhang, Zengli Guo, et al.. (2020). The SKI proto-oncogene restrains the resident CD103+CD8+ T cell response in viral clearance. Cellular and Molecular Immunology. 18(10). 2410–2421. 12 indexed citations
16.
Guo, Zengli, Gang Wang, Bing Wu, et al.. (2020). DCAF1 regulates Treg senescence via the ROS axis during immunological aging. Journal of Clinical Investigation. 130(11). 5893–5908. 117 indexed citations
17.
Hu, Liu, Shuang Geng, Bo Wang, et al.. (2015). Immuno-potentiating pathway of HBsAg-HBIG immunogenic complex visualized. Human Vaccines & Immunotherapeutics. 12(1). 77–84. 6 indexed citations
18.
Wang, Shuang, Bing Wu, Jia Xue, et al.. (2013). Nizatidine, a small molecular compound, enhances killed H5N1 vaccine cell-mediated responses and protects mice from lethal viral challenge. Human Vaccines & Immunotherapeutics. 10(2). 461–468. 7 indexed citations
19.
Jin, Jin, Qiang Zou, Chen Xuan, et al.. (2012). Interleukin-21 Inhibits Humoral Response to an HIV DNA Vaccine by Enhancing Bcl-6 and Pax-5 Expression. Viral Immunology. 25(2). 131–140. 4 indexed citations
20.
Zou, Qiang, Xin Yao, Zhinan Yin, et al.. (2011). Praziquantel Facilitates IFN-γ-Producing CD8+ T Cells (Tc1) and IL-17-Producing CD8+ T Cells (Tc17) Responses to DNA Vaccination in Mice. PLoS ONE. 6(10). e25525–e25525. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Si Breakdown of academic impact, for papers by Kiva Brennan Breakdown of academic impact, for papers by Tara A. Sheldrake Breakdown of academic impact, for papers by Cynthia Louis Breakdown of academic impact, for papers by Lucía Cabal‐Hierro Breakdown of academic impact, for papers by Yeny Martinez de la Torre Breakdown of academic impact, for papers by David Saliba Breakdown of academic impact, for papers by Tiina Kelkka Breakdown of academic impact, for papers by Morteza Motallebnezhad Breakdown of academic impact, for papers by Simone Vogel
Rankless by CCL
2026